# Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia

Study · id `cardio:ct-nct04276155` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04276155](<https://clinicaltrials.gov/study/NCT04276155>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04276155

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Stroke; Heart rhythm problems; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 500 participants.

## Technical summary

Registry record NCT04276155. Randomized; no masking; primary purpose treatment. Start 2021-08-03 (actual); primary completion 2027-06-22 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT04276155, source copy `cardio:ctgov-nct04276155-2026-03-23`, retrieved 2026-10-26)
- Started: 2021-08-03 (actual) (ClinicalTrials.gov record NCT04276155, source copy `cardio:ctgov-nct04276155-2026-03-23`, retrieved 2026-10-26)
- Primary completion: 2027-06-22 (anticipated) (ClinicalTrials.gov record NCT04276155, source copy `cardio:ctgov-nct04276155-2026-03-23`, retrieved 2026-10-26)
- Completion: 2027-06-22 (anticipated) (ClinicalTrials.gov record NCT04276155, source copy `cardio:ctgov-nct04276155-2026-03-23`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT04276155, source copy `cardio:ctgov-nct04276155-2026-03-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04276155-2026-03-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia
- Acronym: SCA FA
- Condition: Atrial Fibrillation, Myocardial Infarction
- Intervention (Drug): non-systematic prescription of anticoagulant therapy
- Lead sponsor: Centre Hospitalier de PAU
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)

## Provenance

Content hash: 9bf9f12c5011fe5c1f0956f370d0dda80257fc53b79a60aaf0694e58174c1668
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
